InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Equillium, Inc.

EQ Clue Score53
United States Fiscal year ends December CIK 0001746466 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

18
Insider
Date
Role
Action
Shares
Price
Amount
Stephen Connelly
5 Jun 2026
President and CSO
Sell
30,975
$2.94
$91.07K
Christine Zedelmayer
5 Jun 2026
Sr. Vice President and COO
Sold after exercise
14,584
$2.93
$42.74K
Stephen Connelly
4 Jun 2026
President and CSO
Sell
200,000
$3.16
$632.76K
Christine Zedelmayer
28 May 2026
Sr. Vice President and COO
Sold after exercise
30,208
$2.98
$90.02K
Christine Zedelmayer
28 May 2026
Sr. Vice President and COO
Sold after exercise
200
$2.71
$542.00
Christine Zedelmayer
28 May 2026
Sr. Vice President and COO
Sold after exercise
55,604
$2.70
$150.13K
Penny Tom
28 May 2026
Principal Accounting Officer
Sold after exercise
65,000
$2.95
$191.75K
Christine Zedelmayer
27 May 2026
Sr. Vice President and COO
Sold after exercise
9,821
$2.70
$26.52K
Christine Zedelmayer
13 Mar 2026
Sr. Vice President and COO
Sold after exercise
120,312
$2.50
$300.82K
Christine Zedelmayer
9 Mar 2026
Sr. Vice President and COO
Sold after exercise
181,219
$2.00
$362.44K
Christine Zedelmayer
19 Feb 2026
Sr. Vice President and COO
Sold after exercise
76,562
$1.74
$133.26K
Christine Zedelmayer
19 Feb 2026
Sr. Vice President and COO
Sold after exercise
109,375
$1.78
$194.84K
Penny Tom
8 Jan 2026
Principal Accounting Officer
Sold on a plan
6,533
$1.29
$8.43K
Christine Zedelmayer
23 Dec 2025
Sr. Vice President and COO
Sold after exercise
100,000
$1.50
$150.00K
Christine Zedelmayer
15 Dec 2025
Sr. Vice President and COO
Sold on a plan
11,900
$1.31
$15.59K
Christine Zedelmayer
12 Dec 2025
Sr. Vice President and COO
Sold on a plan
23,804
$1.34
$31.90K
Christine Zedelmayer
25 Nov 2025
Sr. Vice President and COO
Sold on a plan
7,998
$0.95
$7.60K
Christine Zedelmayer
25 Nov 2025
Sr. Vice President and COO
Sold on a plan
100
$0.98
$98.00

What was left out

Form 4 filings counted 19
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 11
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 734,027
History held since 16 Oct 2018